Adding Immune-based Treatments to Standard Glioblastoma Therapy
This clinical trial is testing standard therapy (surgery, radiation and temozolomide) plus immunotherapy with pembrolizumab with or without a cancer treatment vaccine for patients with newly diagnosed glioblastoma, a common and deadly type of brain tumor.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1097676.htm
- Syndication ID: 19481
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:13 PM
- Date Syndication Updated: Thursday, July 22, 2021 at 06:11 AM
Embed Code Snippet
To get the embed code snippet please Login.
